Article Versions Notes

Kannt A, Rajagopal S, Hallur MS, Swamy I, Kristam R, Dhakshinamoorthy S, Czech J, Zech G, Schreuder H, Ruf S. Novel Inhibitors of Nicotinamide-N-Methyltransferase for the Treatment of Metabolic Disorders. Molecules. 2021; 26(4):991. https://doi.org/10.3390/molecules26040991

Kannt, Aimo, Sridharan Rajagopal, Mahanandeesha S. Hallur, Indu Swamy, Rajendra Kristam, Saravanakumar Dhakshinamoorthy, Joerg Czech, Gernot Zech, Herman Schreuder, and Sven Ruf. 2021. "Novel Inhibitors of Nicotinamide-N-Methyltransferase for the Treatment of Metabolic Disorders" Molecules 26, no. 4: 991. https://doi.org/10.3390/molecules26040991

Kannt, A., Rajagopal, S., Hallur, M. S., Swamy, I., Kristam, R., Dhakshinamoorthy, S., Czech, J., Zech, G., Schreuder, H., & Ruf, S. (2021). Novel Inhibitors of Nicotinamide-N-Methyltransferase for the Treatment of Metabolic Disorders. Molecules, 26(4), 991. https://doi.org/10.3390/molecules26040991